Archive

EASD 2021: Osteoporosis drug appears to lower diabetes risk

Written by | 5 Oct 2021

Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the […]

Standing more may help prevent chronic diseases

Written by | 17 Sep 2021

Insulin is a key hormone in energy metabolism and blood sugar regulation. Normal insulin function in the body may be disturbed by e.g. overweight, leading to decreased insulin […]

Pharmacist led Type 2 diabetes intervention reverses medication use

Written by | 16 Sep 2021

Persons with Type 2 diabetes can, through diet and pharmacist supervision, eliminate the need for diabetes medications, researchers reported on Sept. 10, 2021 in Nature Communications. “There is […]

Synthetic hinge could hold key to revolutionary ‘smart’ insulin therapy

Written by | 7 Aug 2021

For people with diabetes who are insulin dependent, glycemic control is a full-time job. But what if their medication could do the work for them — an insulin […]

Antidepressants may improve outcomes in persons with diabetes and depression

Written by | 31 Jul 2021

Researchers report that patients diagnosed with both diabetes and depression who are treated with antidepressants appear to achieve a lower risk of death and of serious diabetes complications. […]

New Soliqua data shows improved blood sugar control without weight gain versus premixed insulin – Sanofi

Written by | 9 Jul 2021

A new study of Soliqua (insulin glargine 100 Units/mL and lixisenatide, (iGlarLixi) met its two primary endpoints and all key secondary endpoints in a head-to-head comparison against premixed […]

Insulet’s Omnipod 5 automated insulin delivery system improves clinical outcomes in type 1 diabetes

Written by | 28 Mar 2021

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, announced positive results from the first pivotal trial […]

Lifestyle intervention almost halves risk of Type 2 diabetes

Written by | 4 Jan 2021

Among persons with prediabetes, a lifestyle intervention can almost halve the risk of developing Type 2 diabetes, researchers from a large, new study reported on Nov. 13, 2020 […]

Diabetes drug canagliflozin slows advanced kidney disease

Written by | 2 Jan 2021

The diabetes drug canagliflozin, which has already shown efficacy in slowing kidney disease, is also effective among patients with advanced kidney disease. Researchers reported these findings in the […]

Green tea and coffee linked to lower death risk in people with diabetes

Written by | 6 Nov 2020

4 or more cups of green tea + 2 or more of coffee linked to 63% lower all cause mortality Drinking plenty of both green tea and coffee […]

Metformin appears to slow cognitive decline in Type 2 Diabetes

Written by | 10 Oct 2020

Treatment of Type 2 diabetes with metformin appears to inhibit cognitive decline and development of dementia in older patients, researchers reported on Sept. 23, 2020 in Diabetes Care. “We’ve […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.